BOSTON (PRWEB) July 23, 2019
A registered patent attorney, Buchanan prepares, files, and prosecutes U.S. and international patent applications related to technologies such as small molecules, antibodies, organic chemistry, medicinal chemistry, pharmaceuticals, biotechnology, and nanoparticles, for life science companies and academic institutions.
Buchanan has more than 20 years of experience working as a medicinal chemist in the pharmaceutical industry. He has contributed to programs covering compounds for the treatment of cancer, bacterial infections, inflammation, osteoporosis, and pain, and is the co-inventor of 14 patent applications, which have resulted in the issuance of 12 U.S. patents.
Buchanan obtained his J.D. from Boston College Law School, Ph.D. in Organic Chemistry from the University of Wisconsin-Madison, and B.S. in Chemistry and Mathematics from Hope College.
About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to over 70 attorneys practicing in the areas of bankruptcy, business aviation, corporate, emerging technology, energy, gaming, governmental affairs, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,100 attorneys in 41 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.
Share article on social media or email: